more eloquently. They keep trying, and the FDA keeps refusing to approve them for human use. There are a lot of different factors, but let me focus on the most annoying one. So why is the government having so much trouble permitting a usable form of a common medication?
But aside from the EpiPen itself, only one competitor has ever made it past the FDA and onto the pharmacy shelf a system called. This got held up for a while because the FDA didnt like the name ( really! Once again, the original manufacturers sued for patent infringement.
The problem with the pharmaceutical industry isnt that theyre unregulated just like chairs and mugs. When Mylan decided to sell EpiPens for 300, in any normal system somebody would have made their own EpiPens and sold them for less. Let me ask Vox a question: when was the last time that Americas chair industry hiked the price of chairs 400 and suddenly nobody in the country could afford to sit down? In 2010, another group, Sandoz, asked for permission to sell a generic EpiPen. The bill would ban pharmaceutical companies from bribing generic companies not to create generic drugs. We are the only developed nation that lets drugmakers set their own prices, maximizing profits the same way sellers of chairs, mugs, shoes, or any other manufactured goods would. None of this is because EpiPens are just too hard to make correctly. This is apparently so that children who have learned how to use an EpiPen dont have to relearn how to use an entirely different device (hint: jam the pointy end into your body). Its active ingredient, epinephrine, is off-patent, was being synthesized as early as 1906, and costs about ten cents per EpiPen-load.